Motion stimulation therapy is a form of physical therapy utilized when muscle denervation and paralysis or weakness occur due to an event such as a stroke or spinal cord injury. It aids in producing the voluntary forces required for joint movements, facilitating functional performance of daily tasks.
In FY 2022, the Motion Stimulation Therapy Market Size was held at around US$ 1.2 million. Between 2022 and 2032, the market is expected to expand at a CAGR of 4.1%, reaching US$ 1.8 million.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8419
Motion stimulation therapy can alleviate muscle spasms, reduce pain and inflammation, and prevent muscle atrophy. It can also help with Parkinson’s disease, a progressive neurodegenerative disorder that primarily affects the elderly.
Deep brain stimulation is a motion stimulation therapy used to treat Parkinson’s disease, and is the most common surgical treatment for the condition. Advanced motion stimulation therapies, such as functional and therapeutic electric stimulation, are also widely used for better outcomes and faster recovery from muscular dysfunction. These therapies employ devices that contract and stimulate muscles using electrical impulses.
Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth?
The growth of the motion stimulation market is primarily driven by the increasing prevalence of Parkinson’s disease, as well as the rising incidence of traffic accidents and muscle injuries. Motion stimulation therapy is often used in combination with standard medication, which is expected to drive market growth further. Additionally, advancements in stimulator device technology are also contributing to market growth.
The global Motion Stimulation Therapy market is expected to experience significant growth during the forecast period, with government funding for novel drug development being a key driver. According to the Parkinson’s Association of the Carolinas, approximately 60,000 people in the United States are diagnosed with Parkinson’s disease annually, with an estimated 10 million people worldwide living with the disease.
Contact us for discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-8419
Due to the increasing prevalence of Parkinson’s disease globally, the functional neuromuscular stimulation therapy segment is expected to hold the highest market share in the motion stimulation therapy market. Hospitals are anticipated to be the most dominant end-user segment, driven by the growing number of patients seeking motion stimulation therapy.
How is North America Contributing to the Growth of the Motion stimulation therapy Market?
Because of the rising incidences of musculoskeletal disorders and rising fitness awareness, the motion stimulation therapy market is expected to grow at a CAGR of 4.8 percent during the forecast period in North America. For example, the World Health Organization (WHO) reported in February 2021 that around 1.71 billion people worldwide suffer from musculoskeletal disorders.
Because of high spending on healthcare products, favorable reimbursement policies, and increased adoption among sedentary consumers, the North American region is well-positioned to reign supreme in the global muscle stimulation devices market.
Key Companies Profiled:
Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation
Get Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8419
Key Segments Covered in the Motion Stimulation Therapy Market Study
Motion Stimulation Therapy Market by Therapy Type:
- Functional Neuromuscular Motion Stimulation Therapy
- Peripheral Motion Stimulation Therapy
- Deep Brain Motion Stimulation Therapy
- Therapeutic Electrical Motion Stimulation Therapy
Motion Stimulation Therapy Market by End User:
- Motion Stimulation Therapy across Hospitals
- Motion Stimulation Therapy across Specialty Clinics
- Motion Stimulation Therapy across Other End User
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
